Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo
- PMID: 15542180
- DOI: 10.1016/j.vaccine.2004.07.018
Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo
Abstract
The adenylate cyclase (CyaA) produced by Bordetella pertussis is able to deliver CD8+ and CD4+ T-cell epitopes genetically grafted within the catalytic domain of the molecule into antigen presenting cells in vivo. We develop now a new approach in which peptides containing CD8+ epitopes are chemically linked to CyaA. We show that CTL responses were induced in mice immunized with CyaA bearing these CD8+ epitopes. Moreover, we demonstrate that the OVA257-264 CD8+ epitope chemically grafted to CyaA is presented to CD8+ T cells by a mechanism requiring (1) proteasome processing, (2) TAP and (3) neosynthesis of MHC class I molecules. Thus, this novel strategy represents a very versatile system as a single CyaA carrier protein could be easily and rapidly coupled to any desired synthetic peptide.
Similar articles
-
Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.Infect Immun. 2006 Apr;74(4):2277-85. doi: 10.1128/IAI.74.4.2277-2285.2006. Infect Immun. 2006. PMID: 16552058 Free PMC article.
-
The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.Int J Med Microbiol. 2004 Apr;293(7-8):571-6. doi: 10.1078/1438-4221-00291. Int J Med Microbiol. 2004. PMID: 15149033 Review.
-
In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells.Eur J Immunol. 2002 Nov;32(11):3071-81. doi: 10.1002/1521-4141(200211)32:11<3071::AID-IMMU3071>3.0.CO;2-A. Eur J Immunol. 2002. PMID: 12385027
-
Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.J Immunol. 1999 Apr 1;162(7):4157-62. J Immunol. 1999. PMID: 10201941
-
The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells.Toxicon. 2002 Dec;40(12):1661-5. doi: 10.1016/s0041-0101(02)00205-2. Toxicon. 2002. PMID: 12457876 Review. No abstract available.
Cited by
-
Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy.Toxins (Basel). 2018 Jul 20;10(7):302. doi: 10.3390/toxins10070302. Toxins (Basel). 2018. PMID: 30037010 Free PMC article. Review.
-
Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.Med Microbiol Immunol. 2018 Feb;207(1):3-26. doi: 10.1007/s00430-017-0524-z. Epub 2017 Nov 21. Med Microbiol Immunol. 2018. PMID: 29164393 Review.
-
Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.Future Microbiol. 2010 Mar;5(3):455-69. doi: 10.2217/fmb.09.133. Future Microbiol. 2010. PMID: 20210554 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous